CombiMatrix's Sales Drop in First Quarter | GenomeWeb

NEW YORK (GenomeWeb News) – CombiMatrix reported after the close of the market on Wednesday that its first-quarter revenues tumbled 23 percent year over year on weak government contracts and product sales.

CombiMatrix brought in total revenues of $1.5 million for the three-month period ended March 31, compared to total revenues of $2 million in the period a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.